CROI 2019 Seattle: Meg Doherty

Natella Rakhmanina, George Washington University, interviews Meg Doherty, World Health Organization, at the 2019 Retrovirus Conference in Seattle. They discussed where we are currently in the global knowlege around Dolutegravir, and the side-effects of Dolutegravir, and potentially the signal of risk in neural tube defects during the periconception period. They followed on with a discussion of how we can move forward with guidance and guidelines around the integration of HIV and other broader infectious diseases and non-communicable diseases.